{"id":1012597,"date":"2026-10-22T10:20:13","date_gmt":"2026-10-22T14:20:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/"},"modified":"2026-10-22T10:20:13","modified_gmt":"2026-10-22T14:20:13","slug":"collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/","title":{"rendered":"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>STOUGHTON, Mass., Oct.  22, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=m7kuhfmmzgXqXPVEYVF878Vbr0FQiWbS98WEf7zM4mAsHawhNOq5uf-WrWK3XQo79hj5M3sXhzApO-QKBKzGZ7FlWXgASTe1OHtWjWLmKzh8gDIlUwVrreyxkybczckNgTigXJP8xn4rYsbCIC4n0OwnsLQP7nXmcjrfxJ1HQE4FLmKg6mfmdwrUNO3MdXaCqRlF90T5mxJPh6oMwe3WFlk2wDz5k8HNqDlJw7zLmZB9c289kn5W2y1-lAJ3WirEQfTr_bg4o6Aw7XqvT6CqIdlVaF7cuv0NXKV6K-Aor7a511fuGgwOKGESTrPpr8VO\" rel=\"nofollow\" target=\"_blank\">Collegium Pharmaceutical, Inc.<\/a> (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that it will report third quarter 2026 financial results before the market opens on Thursday November 5, 2026. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET.<\/p>\n<p>\n        <strong>Conference Call Information\u00a0<\/strong><br \/>\n        <br \/>To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the \u201cCollegium Pharmaceutical Q3 2026 Earnings Call.\u201d An audio webcast will be accessible from the Investors section of the Company\u2019s website:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=59kDGgYMFgYfkH1u6Qcbnttdlxoq3LVW8nFbpK7wiSiU-XspJB0guivjI3COWpjX7jNuRlcV52E3dqNUKi8-lIj5-DzAt-KAdyf0XNnIwxkH06K1KqxJuGRAotjs0pK7pizghpd710ZhX0PiMFku2Qvk-vtnI7gtbcRL2-K9Vnn2qGtscpzu0mweLFL7uge3oLukrDeOMg_aHNQhChb1gGidHN5-RNRzLhnAYrG-fQC1aLPHKBlulxxCBC1Lv-i9tWp99pLXs9DlHede923hag==\" rel=\"nofollow\" target=\"_blank\">www.collegiumpharma.com<\/a>. The webcast will be available for replay on the Company\u2019s website approximately two hours after the event.<\/p>\n<p>\n        <strong>About\u00a0Collegium Pharmaceutical, Inc.<\/strong><br \/>\n        <br \/>Collegium Pharmaceutical is a dynamic biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system (CNS) and pain conditions. \u00a0Collegium has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions.\u00a0 \u00a0\u00a0<\/p>\n<p>With a portfolio of differentiated ADHD medications, anchored by JORNAY PM<sup>\u00ae <\/sup>(methylphenidate HCl)\u00a0CII\u00a0and AZSTARYS<sup>\u00ae <\/sup>(serdexmethylphenidate\u00a0and dexmethylphenidate)\u00a0CII, and an established leadership position in responsible pain management, Collegium leads with the scientific rigor and commercial expertise to deliver treatment options around how people live their lives. \u00a0<\/p>\n<p>For more information, please visit\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yZLyElelRkwKOfO1hY17wC5fR7htAX3gZqzdV2oeWA81uHy85fmhcLfTb1jE4kZDYYZIEA4UDoiv-WsT_SC13xGEDTDnNJRdyXyHVVGUujs=\" rel=\"nofollow\" target=\"_blank\">collegiumpharma.com<\/a>\u00a0or find us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yh1oY2r604t767eR3tdHzrYjv7UQIv_k8b9inqfq91H-4If37ILf-LmqdNqcwFHdhs0GjmKKPyeI315MKPkR_AF-GKYntLEhRcEb2RHu6vF0nu3r70b1x0yBAy6452_4WboaXS9GJ07HRitEKlOutA==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.\u00a0 \u00a0<\/p>\n<p>\n        <strong>Investor Contacts:<\/strong><br \/>\n        <br \/>Ian Karp<br \/>Head of Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IPJZjH0qZtGaaBuz7LJfhTRAvDiLz4ChD-o0zfTkl_PUgPt--MCJpY97jQJnB3-b8GMZE6ZCQGurmolP9Ci7IzO0SOYXHsln3zHsmbREq-A5h-ZZo1gmjLeYYhFRvDg1leToIzU28jh60QVa-mCvDPO5U36nPFosJlxnnMJPz9Cy66tcyOab4TrjdaiX2FIyu0q7CXUXJjZ7T_rU9XMNCmMU_OPS7n0UHUVtse6QVxWKh73AY3PFJ2-GvBwFhcN_TM_IKTibuS-l5a1Ff9XRnSNDiBcAVCofSvWzloatx_WDodMHWGyGhMbv9NNi7QWyyBYvhD17a62jvNvJwpWfW5JspIZA--WzGw09Uzr0LVYsMvdx3HxGYQe4ETW4xe6Wmj_4QSxKtRA4H-x-CU6kyvUtxHiMIY31Bmy_gPMzRF5HrX8V7olx3b2wsRDTe0912b0wcNncxu8ybo1CkMptOy1NGOMX3y8tKduuVhH1tWgEQlaIzaBzBcE3yzBs-eqU\" rel=\"nofollow\" target=\"_blank\">ir@collegiumpharma.com<\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Jessica Cotrone<br \/>Senior Vice President, Communications &amp; Corporate Affairs<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-L2PHw1mKO9AOsh6BcItBF-PeOyo6P3VirlCLO_NQWZ0LlU9z3SCt-NG_S7eW_BZ562cXu3PQD0S6PSZnDvU-kMDZdT_sx7KI_fM-7vtbuVK8qsyGkkinTi95RFfHfNc1QP3-d8KzVYOi4xt_2ADdg==\" rel=\"nofollow\" target=\"_blank\">communications@collegiumpharma.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OGU2NTVlMzgtZTVkNC00NTVjLThiMDQtYjJiY2E2OWZmMDQyLTEwMzAyOTYtMjAyNi0xMC0yMi1lbg==\/tiny\/Collegium-Pharmaceutical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>STOUGHTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that it will report third quarter 2026 financial results before the market opens on Thursday November 5, 2026. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET. Conference Call Information\u00a0 To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the \u201cCollegium Pharmaceutical Q3 2026 Earnings Call.\u201d An audio webcast will be accessible from the Investors section of the Company\u2019s website:\u00a0www.collegiumpharma.com. The webcast will be available for replay on the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1012597","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"STOUGHTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that it will report third quarter 2026 financial results before the market opens on Thursday November 5, 2026. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET. Conference Call Information\u00a0 To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the \u201cCollegium Pharmaceutical Q3 2026 Earnings Call.\u201d An audio webcast will be accessible from the Investors section of the Company\u2019s website:\u00a0www.collegiumpharma.com. The webcast will be available for replay on the &hellip; Continue reading &quot;Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-22T14:20:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026\",\"datePublished\":\"2026-10-22T14:20:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/\"},\"wordCount\":278,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/\",\"name\":\"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM=\",\"datePublished\":\"2026-10-22T14:20:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/","og_locale":"en_US","og_type":"article","og_title":"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk","og_description":"STOUGHTON, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) &#8212; Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that it will report third quarter 2026 financial results before the market opens on Thursday November 5, 2026. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET. Conference Call Information\u00a0 To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the \u201cCollegium Pharmaceutical Q3 2026 Earnings Call.\u201d An audio webcast will be accessible from the Investors section of the Company\u2019s website:\u00a0www.collegiumpharma.com. The webcast will be available for replay on the &hellip; Continue reading \"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-22T14:20:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026","datePublished":"2026-10-22T14:20:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/"},"wordCount":278,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/","name":"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM=","datePublished":"2026-10-22T14:20:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg0OTQ4MyM3OTAwMzAxIzIwMTg3MjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/collegium-to-report-third-quarter-2026-financial-results-on-november-5-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Collegium to Report Third Quarter 2026 Financial Results on November 5, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1012597"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012597\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1012597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1012597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1012597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}